Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry
Year: 2024
Type: article
Abstract: The US Food and Drug Administration says that it takes conflicts of interest seriously. But financial entanglements with the drug industry are common among its leaders. Peter Doshi reports
Source: BMJ
DOI: 10.1136/bmj.q975
Author: Peter Doshi
Institution: BMJ Group (United Kingdom)
Language: English
Subfield: Issues, ethics and legal aspects
Field: Nursing
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4396724157
